Effect of Statins on Sympathetic Activity in Hypertensive Patients with Chronic Kidney Disease.

Effect of Statins on Sympathetic Activity in Hypertensive Patients with Chronic Kidney Disease: a Randomized trial in Hypertensive Patients with Chronic Kidney Disease.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON28420

Enrollment

Registered

2009-04-27

Start date

2009-08-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease, hypertension

Interventions

Statins added to ARB or ACEi.

Eligibility

Inclusion criteria

Inclusion criteria: Patients older than 18 years old with stable chronic kidney disease and hypertension are included in this project.

Exclusion criteria

Exclusion criteria: Patients with diabetes mellitus, patients on renal replacement therapy, patients on antihypertensive medication (which cannot be stopped), patients on immunosuppressive treatment are excluded.

Design outcomes

Primary

Measure	Time frame
Suppression of sympathetic nerve activity.	—

Secondary

Measure	Time frame
The effect of statin on kidney function and PRA in hypertensive patients with CKD.	—

Contacts

Public ContactL. Siddiqi

l.siddiqi@umcutrecht.nl+31 (0)88 755 7379

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)